Table of Contents
Table of Contents
Preface
Specialty Drugs: Background and Policy Concerns
(Suzanne M. Kirchhoff)
Prescription Drug Discount Coupons: Implications for Public and Commercial Health Care Plans
(Suzanne M. Kirchhoff)
Manufacturer Safeguards May Not Prevent Copayment Coupon Use for Part D Drugs
(Office of Inspector General)
Pharmaceutical Patent-Antitrust: Reverse Payment Settlements and Product Hopping
(John R. Thomas)
Index